Session Details
JSNM Oral 15:Oncology 7: PRRT 2
Fri. Nov 14, 2025 8:30 AM - 9:20 AM JST
Fri. Nov 14, 2025 11:30 PM - 12:20 AM UTC
Fri. Nov 14, 2025 11:30 PM - 12:20 AM UTC
Room 2（1F, Exhibition Hall 2 A, Kyoto International Exhibition Hall 'Miyako Messe'）
座長：伊藤 公輝（国立研究開発法人 国立がん研究センター 放射線診断科）、奥山 智緒（滋賀県立総合病院 臨床研究センターPETイメージング部門）
[2-MO15-1]Retrospective study of neuroendocrine tumour cases that failed to complete PRRT treatment
Kayako Isohashi1,2、Daisuke Katayama1,2、Shinichiro Watanabe1,2、Hidetaka Sasaki2、Isamu Yabata2、Takashi Kamiya2、Tadashi Watabe1,2、Hiroki Kato2、Mistuaki Tatsumi1,2、Noriyuki Tomiyama1,2 (1.Department of Radiology, Graduate School of Medicine, Osaka University、2.Department of Nuclear Medicine, Osaka University Hospital)
[2-MO15-2]A case of mediastinal NET with cardiac metastasis and invasion treated with PRRT
Junko Hara1、Shigeyasu Sugawara1,2、Ryo Yamakuni1、Hiroki Suenaga1、Shozo Okamoto2、Shiro Ishii1、Kenji Fukushima1、Hiroshi Ito1,2、Tohru Shiga2、Noboru Oriuchi2 (1.Department of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, Japan、2.Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan)
[2-MO15-3]Current status and tasks of PRRT in the inpatient room
Kazuhiko Nakamura1、Miho Kawakami2、Mizuki Hashimoto3、Kensuke Matsumoto1、Tomohiko Tanino1、Chie Inoue1、Eiji Matsusue1 (1.Department of Radiology, Tottori Prefectural Central Hospital、2.Tottori City, Japan、3.Tottori City, Japan)
[2-MO15-4]Diagnostic performance of68Ga-DOTATATE PET/CT for neuroendocrine neoplasms in Japan
Kimiteru Ito1、Noritoshi Kobayashi2、Kouki Nio3、Kenji Hirata4、Yuji Nakamoto5、Anri Inaki6、Nao Fujimori7 8、Fumika Shimada8、Masahiko Sato8、Takahiro Tsuchikawa9 (1.Department of Diagnostic Radiology, National Cancer Center, Tokyo, Japan、2.Department of Oncology, Yokohama City University School of Medicine, Yokohama, Japan、3.Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan、4.Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan、5.Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan、6.Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center/Department of Nuclear Medicine, Kanazawa University, Kanazawa, Japan、7.Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan、8.Novartis Pharma K.K., Tokyo, Japan、9.Department of Gastroenterological Surgery II, Hokkaido University Hospital, Hokkaido, Japan)
[2-MO15-5]accumulation comparison between177Lu-oxodotreotide and111In-pentetreotide in NET Pts
Keiichirou Yamaguchi1、Yuuichirou Takamatsu1、Daichi Kobayashi1、Tomokio Satou2、Yuri Ogawa2 (1.Department of Diagnostic Radiology, St. Marianna University, Kawasaki, Kanagawa、2.Department Radiology, St. Marianna University Hospital, Kawasaki, Kanagawa)